My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 491

    1.

    Soluble tumor necrosis factor-alpha receptors in young obese subjects with normal and impaired glucose tolerance.

    Dzienis-Straczkowska S, Straczkowski M, Szelachowska M, Stepien A, Kowalska I, Kinalska I.

    Diabetes Care. 2003 Mar;26(3):875-80.PMID: 12610052 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Changes in tumor necrosis factor-alpha system and insulin sensitivity during an exercise training program in obese women with normal and impaired glucose tolerance.

    Straczkowski M, Kowalska I, Dzienis-Straczkowska S, Stepién A, Skibińska E, Szelachowska M, Kinalska I.

    Eur J Endocrinol. 2001 Sep;145(3):273-80.PMID: 11517007 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Increased plasma-soluble tumor necrosis factor-alpha receptor 2 level in lean nondiabetic offspring of type 2 diabetic subjects.

    Straczkowski M, Kowalska I, Stepien A, Dzienis-Straczkowska S, Szelachowska M, Kinalska I.

    Diabetes Care. 2002 Oct;25(10):1824-8.PMID: 12351485 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Plasma levels of soluble tumor necrosis factor-alpha receptors are related to total and LDL-cholesterol in lean, but not in obese subjects.

    Straczkowski M, Kowalska I, Nikolajuk A, Adamska A, Karolczuk-Zarachowicz M, Karczewska-Kupczewska M, Kozlowska A, Gorska M.

    Cardiovasc Diabetol. 2006 Jun 27;5:14.PMID: 16803616 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-alpha system.

    Straczkowski M, Dzienis-Straczkowska S, Stêpieñ A, Kowalska I, Szelachowska M, Kinalska I.

    J Clin Endocrinol Metab. 2002 Oct;87(10):4602-6.PMID: 12364441 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Serum levels of soluble tumor necrosis factor-alpha receptor 2 are linked to insulin resistance and glucose intolerance in children.

    Gupta A, Ten S, Anhalt H.

    J Pediatr Endocrinol Metab. 2005 Jan;18(1):75-82.PMID: 15679072 [PubMed - indexed for MEDLINE]Related articles

    7.

    Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients.

    Miyazaki Y, Pipek R, Mandarino LJ, DeFronzo RA.

    Int J Obes Relat Metab Disord. 2003 Jan;27(1):88-94.PMID: 12532159 [PubMed - indexed for MEDLINE]Related articles

    8.

    Elevated soluble intercellular adhesion molecule-1 levels in obesity: relationship to insulin resistance and tumor necrosis factor-alpha system activity.

    Straczkowski M, Lewczuk P, Dzienis-Straczkowska S, Kowalska I, Stepień A, Kinalska I.

    Metabolism. 2002 Jan;51(1):75-8.PMID: 11782876 [PubMed - indexed for MEDLINE]Related articles

    9.

    Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance.

    Fernández-Real JM, Broch M, Ricart W, Casamitjana R, Gutierrez C, Vendrell J, Richart C.

    Diabetes. 1998 Nov;47(11):1757-62.PMID: 9792545 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    [Insulin resistance in obese subjects with impaired glucose tolerance. Studies with hyperinsulinemic euglycemic clamp technique]

    Straczkowski M, Dzienis-Straczkowska S, Szelachowska M, Kowalska I, Stepień A, Kinalska I.

    Pol Arch Med Wewn. 2003 Apr;109(4):359-64. Polish. PMID: 12931487 [PubMed - indexed for MEDLINE]Related articles

    11.

    Relationship between plasma leptin levels and the tumor necrosis factor-alpha system in obese subjects.

    Corica F, Allegra A, Corsonello A, Buemi M, Calapai G, Ruello A, Nicita Mauro V, Ceruso D.

    Int J Obes Relat Metab Disord. 1999 Apr;23(4):355-60.PMID: 10340812 [PubMed - indexed for MEDLINE]Related articles

    12.

    Plasma adiponectin concentration and tumor necrosis factor-alpha system activity in lean non-diabetic offspring of type 2 diabetic subjects.

    Kowalska I, Straczkowski M, Nikołajuk A, Krukowska A, Kinalska I, Górska M.

    Eur J Endocrinol. 2006 Feb;154(2):319-24.PMID: 16452547 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    [Serum concentrations of tumor necrosis factor TNFalpha and its soluble receptors in obese women with diabetes type 2 and without additional disease]

    Olszanecka-Glinianowicz M, Waluszek-Kończakowska I, Zahorska-Markiewicz B, Janowska J.

    Endokrynol Pol. 2005 Mar-Apr;56(2):174-8. Polish. PMID: 16335686 [PubMed - indexed for MEDLINE]Related articles

    14.

    Plasma levels of tumor necrosis factor-alpha, angiotensin II, growth hormone, and IGF-I are not elevated in insulin-resistant obese individuals with impaired glucose tolerance.

    Blüher M, Kratzsch J, Paschke R.

    Diabetes Care. 2001 Feb;24(2):328-34.PMID: 11213887 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Tumor necrosis factor system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy.

    Fernández-Real JM, Molina A, Broch M, Ricart W, Gutiérrez C, Casamitjana R, Vendrell J, Soler J, Gómez-Sáez JM.

    Diabetes. 1999 May;48(5):1108-12.PMID: 10331417 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Lower rate of tumor necrosis factor-alpha -863A allele and higher concentration of tumor necrosis factor-alpha receptor 2 in first-degree relatives of subjects with type 2 diabetes.

    Costa A, Fernández-Real JM, Vendrell J, Broch M, Casamitjana R, Ricart W, Conget I.

    Metabolism. 2003 Aug;52(8):1068-71.PMID: 12898475 [PubMed - indexed for MEDLINE]Related articles

    17.

    Expression pattern of tumour necrosis factor receptors in subcutaneous and omental human adipose tissue: role of obesity and non-insulin-dependent diabetes mellitus.

    Hube F, Birgel M, Lee YM, Hauner H.

    Eur J Clin Invest. 1999 Aug;29(8):672-8.PMID: 10457150 [PubMed - indexed for MEDLINE]Related articles

    18.

    Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects.

    Matsumoto K, Miyake S, Yano M, Ueki Y, Yamaguchi Y, Akazawa S, Tominaga Y.

    Diabetes Care. 1997 Oct;20(10):1562-8.PMID: 9314636 [PubMed - indexed for MEDLINE]Related articles

    19.

    Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance.

    Chavez AO, Molina-Carrion M, Abdul-Ghani MA, Folli F, Defronzo RA, Tripathy D.

    Diabetes Care. 2009 Aug;32(8):1542-6. Epub 2009 Jun 1.PMID: 19487637 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Effect of glucose tolerance status on PAI-1 plasma levels in overweight and obese subjects.

    Pannacciulli N, De Mitrio V, Marino R, Giorgino R, De Pergola G.

    Obes Res. 2002 Aug;10(8):717-25.PMID: 12181379 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity